Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",blood aspartate transaminase amount,,RS:0004633,SD-Fhem1+/+,male,0 days,3,,CMO:0000580,blood aspartate aminotransferase activity level,,,,130.3,U/l,5.8312,10.1,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104929,control condition 2989,"Yu D, et al., Oncotarget. 2016 Sep 20;7(38):61656-61669. doi: 10.18632/oncotarget.11429.",blood aspartate transaminase amount,,RS:0004633,SD-Fhem1+/+,female,0 days,3,,CMO:0000580,blood aspartate aminotransferase activity level,,,,114.7,U/l,8.3138,14.4,MMO:0000179,automated blood analysis,,0.0,,,,,control condition,104930,control condition